<DOC>
	<DOCNO>NCT02965560</DOCNO>
	<brief_summary>Acute-on-chronic liver failure ( ACLF ) ailment high incidence multiorgan failure ( MOF ) consequent mortality . Systemic inflammation susceptibility infection characteristic pathophysiological feature . Prostaglandin E2 ( PGE2 ) could subdue systemic inflammation alleviate liver injury mouse model . However , study evaluate PGE2 predictor early mortality.This study design investigate whether plasma PGE2 receptor associate development MOF predict short-term mortality patient acute-on-chronic liver failure . By way , also measure several potential predictive factor ( C-reactive protein , severe hyponatremia , Second infection , Diabetes mellitus , High density lipoprotein , interleukin-10 , serum bile acid , ferritin , neutrophil lymphocyte ratio , urokinase plasminogen activator receptor , vWF-Ag level FVIII-to-PC ratio ) .</brief_summary>
	<brief_title>Prostaglandin E2 Predicts Outcome Acute-on-chronic Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Clinical diagnosis acuteonchronic liver failure accord AsianPacific Association Study Liver ( APASL ) diagnostic criterion Hepatocellular carcinoma ( HCC ) Portal vein thrombosis Pregnancy Human immunodeficiency virus ( HIV ) Patients receive immunomodulator , cytotoxic/immunosuppressive therapy within least precede 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>